Jane Street
ZVRA icon

Jane Street’s Zevra Therapeutics ZVRA Stock Holding History

Jane Street’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.06M Sell
221,058
-342,848
-61% -$3.09M ﹤0.01% 5031
2025
Q4 		$5.05M Buy
563,906
+349,704
+163% +$3.31M ﹤0.01% 3213
2025
Q3 		$2.04M Buy
214,202
+65,298
+44% +$655K ﹤0.01% 4892
2025
Q2 		$1.31M Buy
+148,904
New +$1.21M ﹤0.01% 5120
2024
Q4 		– Sell
-152,907
Closed -$1.31M – 10782
2024
Q3 		$1.06M Buy
152,907
+107,837
+239% +$732K ﹤0.01% 5768
2024
Q2 		$221K Buy
45,070
+29,728
+194% +$141K ﹤0.01% 8248
2024
Q1 		$89K Sell
15,342
-23,578
-61% -$145K ﹤0.01% 8567
2023
Q4 		$255K Buy
+38,920
New +$182K ﹤0.01% 7868
2023
Q2 		– Sell
-184,812
Closed -$1.02M – 9708
2023
Q1 		$1.02M Buy
184,812
+152,835
+478% +$809K ﹤0.01% 4962
2022
Q4 		$147K Buy
+31,977
New +$162K ﹤0.01% 7876
2022
Q2 		– Sell
-26,878
Closed -$135K – 11111
2022
Q1 		$135K Buy
26,878
+11,478
+75% +$73K ﹤0.01% 9300
2021
Q4 		$134K Buy
+15,400
New +$137K ﹤0.01% 9075
2021
Q2 		– Sell
-159,745
Closed -$1.72M – 10521
2021
Q1 		$1.47M Buy
+159,745
New +$1.39M ﹤0.01% 4654
2020
Q2 		– Sell
-2,199
Closed -$8K – 7661
2020
Q1 		$8K Buy
+2,199
New +$12.2K ﹤0.01% 5206

Other funds holding ZVRA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Jane Street's ZVRA Position: Q1 2026 in Review

Jane Street reduced its Zevra Therapeutics (ZVRA) stake by 61% in Q1 2026, selling an estimated $3.09M and leaving 221,058 shares worth $2.06M. The position accounts for ﹤0.01% of the portfolio, ranked #5031.

Jane Street first reported a position in ZVRA in Q1 2020 and has held it in 14 quarters since. The position peaked at $5.05M in Q4 2025. 148 funds tracked by Wall St. Rank hold ZVRA as of Q1 2026.

  • Jane Street held 221,058 shares of Zevra Therapeutics worth $2.06M as of Q1 2026.
  • Jane Street sold 342,848 Zevra Therapeutics shares in Q1 2026, an estimated $3.09M.
  • Zevra Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #5031 holding.
  • Jane Street first reported a position in Zevra Therapeutics in Q1 2020 and has held it in 14 quarters since.
  • Jane Street's Zevra Therapeutics position peaked at $5.05M in Q4 2025.
  • 148 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.